By Matt Chiappardi ( September 12, 2014, 7:58 PM EDT) -- A Delaware Chancery judge declined Friday to cancel the trial over Bill Ackman and Valeant Pharmaceuticals International Inc.'s bid to compel a special shareholder meeting as part of their $53 billion hostile takeover campaign of Allergan Inc., after the Botox maker argued its OK of the suitors' request mooted the issue....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.